Patent · US Active

Retroviral protease inhibiting compounds

US7968707B2 · kind B2 · utility

0Cited by
29References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 27, 2007
Grant dateJun 28, 2011
Priority date
Expiry dateApr 10, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/12
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A compound of the formula:is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.